Adriforant is a functional antagonist of histamine receptor 4 and attenuates itch and skin inflammation in mice

2023/01/21 by Özge Uluçkan, Özge Uluckan, Sandro Bruno +19
Immunology and Microbiology · Medicine · #Mast cells and histamine #Dermatology and Skin Diseases #Allergic Rhinitis and Sensitization

paper · doi:10.1016/j.ejphar.2023.175533

Citations

• Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*
• Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*